Hypertension

India needs a new healthcare model to effectively manage hypertension

Success will help in reducing government spending for the poor battling the cost of treating non-communicable diseases

India lacks adequate community level data for hypertension control: Lancet

More than 50 per cent of patients in India are unaware of their high blood pressure, finds a study published in Lancet Regional Health Journal

Zydus Lifesciences gets USFDA's nod for generic hypertension drug

Zydus Lifesciences on Tuesday said it has received approval from the US health regulator to market blood pressure lowering drug Bisoprolol Fumarate and Hydrochlorothiazide tablets in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market the generic medication in multiple strengths, the Ahmedabad-based drug maker said in a statement. Bisoprolol Fumarate and hydrochlorothiazide combination is indicated to treat high blood pressure (hypertension). The drug will be manufactured at the company's formulation manufacturing facility at Ahmedabad SEZ, the company said. As per IQVIA MAT September 2022 data, Bisoprolol Fumarate and Hydrochlorothiazide tablets had annual sales of USD 27.1 million in the United States.

No heart issue despite hypertension in patients with short fingers: Study

Researchers in Berlin have spent decades on a peculiar hereditary illness that results in extraordinarily short fingers and incredibly high blood pressure in half of the members of specific families

Most people experience cardiac arrest early in morning, say experts

Doctors have often attributed a cardiac arrest to factors like diabetes, hypertension, smoking and alcohol intake, along with erratic lifestyle and lack of sleep

World Hypertension Day 2022: Dr Naresh Trehan gives tips on dealing with BP

World Hypertension Day 2022: Dr Naresh Trehan, CMD of Medanta, speaks to Business Standard on the spike in hypertension cases in India, the early signs, how to deal with the ailment

Unichem Laboratories gets USFDA approval for generic Nebivolol tablets

Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment of hypertension

Alembic gets USFDA nod for generic hypertension treatment drug

Alembic said it has so far received 15 product approvals this year

India's health report card before Covid-19 pandemic: explained in 6 charts

Food poisoning and diarrhea were the main disease outbreaks in India before the Covid-19 pandemic hit. A look at India's health profile in 2019 through six charts

India needs to do more on hypertension, says Lancet global survey

Marginal increase in the number of people living with the ailment but diagnosis, treatment and control still need to catch up with best practices

Covid vaccination voluntary, those already infected can also get the jab

A detailed FAQ released by health ministry has also addressed issues on suitability in co-morbid cases, delivery procedure among other things

Pollution, hypertension among top 5 risk factors for death in India in 2019

Air pollution, hypertension, tobacco use, poor diet and high blood sugar levels were the top-five risk factors for death in India in 2019 according to a new study

OMRON India enters telemedicine segment via partnership with PhableCare

Healthcare monitoring equipment maker OMRON Healthcare India will provide remote hypertension management services at home

Lupin gets Canadian health regulator approval for hypertension capsules

Lupin is the first generic company to receive an approval for generic Inderal-LA capsules for the Canadian market

Hypertension: A silent killer in India that affects young and old alike

Beware of the hidden salt and sugar and the read the food labels carefully. Make sure you pay close attention to the serving size.